4.585
2.65%
-0.125
JanOne Inc stock is currently priced at $4.585, with a 24-hour trading volume of 57,237.
It has seen a -2.65% decreased in the last 24 hours and a +91.04% rose in the past month.
The chart indicates a potential bearish trend, as the stock is below the $4.68 pivot point. If it approaches the $4.48 support level, significant changes may occur.
Previous Close:
$4.71
Open:
$4.61
24h Volume:
57,237
Market Cap:
$40.48M
Revenue:
$40.02M
Net Income/Loss:
$12.88M
P/E Ratio:
1.3213
EPS:
3.47
Net Cash Flow:
$1.21M
1W Performance:
+15.49%
1M Performance:
+91.04%
6M Performance:
+1,268%
1Y Performance:
+386.21%
JanOne Inc Stock (JAN) Company Profile
Name
JanOne Inc
Sector
Industry
Phone
702 997 5968
Address
325 East Warm Springs Road, Suite 102, Las Vegas, NV
JanOne Inc Stock (JAN) Latest News
Why IPG Photonics Shares Are Trading Lower By Around 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Benzinga
Why ZoomInfo Technologies Shares Are Trading Higher By Around 25%; Here Are 20 Stocks Moving Premarket
Benzinga
Why Green Giant Shares Are Trading Lower By Around 37%; Here Are 20 Stocks Moving Premarket
Benzinga
Why AMC Entertainment Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Benzinga
Why AppLovin Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket
Benzinga
JanOne Inc Stock (JAN) Financials Data
JanOne Inc (JAN) Revenue 2024
JAN reported a revenue (TTM) of $40.02 million for the quarter ending December 31, 2021.
JanOne Inc (JAN) Net Income 2024
JAN net income (TTM) was $12.88 million for the quarter ending September 30, 2023, a +485.92% increase year-over-year.
JanOne Inc (JAN) Cash Flow 2024
JAN recorded a free cash flow (TTM) of $1.21 million for the quarter ending September 30, 2023, a +127.89% increase year-over-year.
JanOne Inc (JAN) Earnings per Share 2024
JAN earnings per share (TTM) was $4.05 for the quarter ending September 30, 2023, a +304.55% growth year-over-year.
About JanOne Inc
JanOne Inc., a clinical-stage biopharmaceutical company, focuses on identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the unmet medical need for the treatment of pain and addiction. It operates through three segments: Biotechnology, Recycling, and Technology. The company's lead product candidate is JAN101, a patented oral and sustained release pharmaceutical composition of sodium nitrite that targets poor blood flow to the extremities in patients with diabetes or peripheral artery disease to treat pain. It also provides turnkey appliance recycling and replacement services for utilities and other sponsors of energy efficiency programs; and designs, develops, and sells cellular transceiver modules and associated wireless services. The company was formerly known as Appliance Recycling Centers of America, Inc. and changed its name to JanOne Inc. in September 2019. JanOne Inc. was founded in 1976 and is headquartered in Las Vegas, Nevada.
Cap:
|
Volume (24h):